Latest Schedule 13G passive stakes

Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin have collectively acquired a 4.97% stake in Enanta Pharmaceuticals, Inc., as disclosed in a Schedule 13G filing.

Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin have reported a 0.0% beneficial ownership of enGene Therapeutics Inc. common shares as of June 30, 2026, indicating a complete divestment.

Farallon Capital Management and affiliated entities have filed a Schedule 13G, reporting a passive ownership stake in Tyra Biosciences, Inc.

Deep Track Capital, LP, along with its affiliates, has reported beneficial ownership of 3,610,000 shares, representing 6.87% of Avalo Therapeutics, Inc. common stock.

Farallon Capital Management and affiliated entities have reported beneficial ownership of 9.8% of Tango Therapeutics' common stock, primarily through warrants and shares.

Farallon Capital Management, L.L.C. and associated entities have reported beneficial ownership of 3,325,000 ordinary shares, representing 2.3% of the class, in InflaRx N.V.

Several PEAK6 affiliated entities and individuals have filed a Schedule 13G, reporting a collective beneficial ownership of 2.5% in eToro Group Ltd. Class A common shares.

Farallon Capital Management, L.L.C. has filed a Schedule 13G, reporting beneficial ownership of 8.3% of Enanta Pharmaceuticals Inc. common stock as of June 30, 2026.

RTW Investments, LP and Roderick Wong, M.D. have filed a Schedule 13G, disclosing beneficial ownership of 5.7% of uniQure N.V.'s ordinary shares as of June 30, 2026.

RTW Investments, LP and Roderick Wong, M.D. have filed a Schedule 13G, disclosing beneficial ownership of 7,796,895 shares of Ultragenyx Pharmaceutical Inc. common stock, representing 7.9% of the class.

RTW Investments, LP and Roderick Wong report beneficial ownership of 2,866,654 shares, representing 9.9% of Tenax Therapeutics, Inc.'s common stock, as of June 30, 2026.

RTW Investments, LP and Roderick Wong have disclosed a beneficial ownership of 4,251,996 shares, representing 4.8% of Spyre Therapeutics, Inc.'s common stock.

RTW Investments, LP, through its managing partner Roderick Wong, has increased its beneficial ownership of RadNet, Inc. common stock to 6.2%, acquiring 4,846,958 shares.

Hood River Capital Management LLC has disclosed beneficial ownership of 7.16% of Red Cat Holdings, Inc. common stock as of June 30, 2026.

Hood River Capital Management LLC has reported a beneficial ownership of 5.37% in LightPath Technologies Inc. as of June 30, 2026.

Hood River Capital Management LLC has disclosed beneficial ownership of 7.64% of Bandwidth Inc.'s common stock as of June 30, 2026.

Hood River Capital Management LLC has reported a 0% beneficial ownership of Camping World Holdings, Inc. common stock, signaling a complete exit from its position.

Hood River Capital Management LLC has reported a zero beneficial ownership of Kura Sushi USA Inc. common stock as of June 30, 2026, indicating a full divestment.

Hood River Capital Management LLC has disclosed a beneficial ownership of 13,190,130 shares, representing 5.61% of Butterfly Network Inc.'s common stock as of June 30, 2026.

Hood River Capital Management LLC has disclosed a beneficial ownership of 8,596,985 shares, representing 8.49% of the common stock in New Era Energy & Digital Inc.

RTW Investments, LP and Roderick Wong, M.D. have filed a Schedule 13G, confirming beneficial ownership of 3,139,030 shares, representing 5.2% of Oruka Therapeutics, Inc. common stock.

S.H.N. Financial Investments Ltd. has filed an amendment to its Schedule 13G, reporting zero beneficial ownership of Zhongchao Inc. Class A Ordinary Shares.

RTW Investments, LP and Roderick Wong, M.D. have jointly filed a Schedule 13G, reporting beneficial ownership of 8.3% of Kailera Therapeutics, Inc. common stock as of June 30, 2026.

S.H.N. Financial Investments Ltd. has amended its Schedule 13G filing, reporting a beneficial ownership of 304,412 warrants, representing 3.8% of Tianci International, Inc.'s common stock.

S.H.N. Financial Investments Ltd. has updated its Schedule 13G filing, reporting beneficial ownership of 601,770 warrants to purchase ordinary shares in Jiuzi Holdings, Inc., representing 1.2% of the class.

S.H.N. Financial Investments Ltd. has filed an amendment to its Schedule 13G, reporting beneficial ownership of 22,301 Pre-Funded Warrants in Farmmi, Inc., representing 0.1% of the class of securities.

RTW Investments, LP and Roderick Wong have disclosed beneficial ownership of 2,182,631 shares, representing 6.6% of iRhythm Holdings, Inc. common stock.

S.H.N. Financial Investments Ltd. has amended its Schedule 13G filing, reporting a reduced beneficial ownership of C3is Inc. common shares and warrants.

RTW Investments, LP and Roderick Wong have reported beneficial ownership of 9.7% of CG Oncology, Inc.'s common stock as of June 30, 2026.

Driehaus Capital Management LLC has reported beneficial ownership of 7.18% of Frequency Electronics, Inc. common stock as of June 30, 2026.